I am a
Home I AM A Search Login

Papers of the Week


2023 Jan 16


Rev Esp Enferm Dig


115

Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study.

Authors

Martín Arranz M D, García-Ramírez L, Martín Arranz E, Montero Vega D, Rueda García J L, Sánchez-Azofra M, Poza Cordón J, Noci Belda J, Verges Martínez-Meco T, Blanco San Miguel P, Suárez-Ferrer C
Rev Esp Enferm Dig. 2023 Jan 16; 115.
PMID: 36645081.

Abstract

response to the SARS-CoV-2 vaccine can be altered in patients with immune-mediated diseases, such as inflammatory bowel disease, and in patients under immunosuppressive treatment. The aims of this study were to evaluate the serologic response to the SARS-CoV-2 vaccine in patients with inflammatory bowel disease, to analyze the influence of immunosuppressive drugs on response, and to describe any adverse events in this population.